A local biotech firm Huons said Thursday it has signed a distribution agreement with Fresenius Medical Care Korea (FMC Korea) for an exclusive sales of Huons’ Pine (heparin sodium) injections 20,000 IU and 25,000 IU in Korea.
Under the agreement, Huons will supply Pine injections, worth 10 billion won, over the next three years.
Heparin is indicated to prevent blood clotting during extrac...
Fees
- Email service daily and homepage access.
- $300 per month.
- 5 Email holders per each company.
- Anual contract base.
Copyright Yakup.com All rights reserved.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.